These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 30642209)
1. Azelaic acid-loaded nanoemulsion with hyaluronic acid - a new strategy to treat hyperpigmentary skin disorders. Jacobus Berlitz S; De Villa D; Maschmann Inácio LA; Davies S; Zatta KC; Guterres SS; Külkamp-Guerreiro IC Drug Dev Ind Pharm; 2019 Apr; 45(4):642-650. PubMed ID: 30642209 [TBL] [Abstract][Full Text] [Related]
2. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Fitton A; Goa KL Drugs; 1991 May; 41(5):780-98. PubMed ID: 1712709 [TBL] [Abstract][Full Text] [Related]
3. Effect of the combination of different depigmenting agents in vitro. Martínez-Gutiérrez A; Asensio JA; Aran B J Cosmet Sci; 2014; 65(6):365-75. PubMed ID: 25898763 [TBL] [Abstract][Full Text] [Related]
4. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541 [TBL] [Abstract][Full Text] [Related]
5. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis. Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516 [TBL] [Abstract][Full Text] [Related]
6. 3-hydroxycoumarin loaded vesicles for recombinant human tyrosinase inhibition in topical applications. Schlich M; Fornasier M; Nieddu M; Sinico C; Murgia S; Rescigno A Colloids Surf B Biointerfaces; 2018 Nov; 171():675-681. PubMed ID: 30107341 [TBL] [Abstract][Full Text] [Related]
7. A possible mechanism of action for azelaic acid in the human epidermis. Schallreuter KU; Wood JW Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832 [TBL] [Abstract][Full Text] [Related]
8. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment. Kamagaju L; Morandini R; Bizuru E; Nyetera P; Nduwayezu JB; Stévigny C; Ghanem G; Duez P J Ethnopharmacol; 2013 Apr; 146(3):824-34. PubMed ID: 23439030 [TBL] [Abstract][Full Text] [Related]
9. Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Nguyen QH; Bui TP Int J Dermatol; 1995 Feb; 34(2):75-84. PubMed ID: 7737781 [No Abstract] [Full Text] [Related]
10. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Sarkar R; Bhalla M; Kanwar AJ Dermatology; 2002; 205(3):249-54. PubMed ID: 12399672 [TBL] [Abstract][Full Text] [Related]
11. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. Del Rosso JQ Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285 [TBL] [Abstract][Full Text] [Related]
12. Nano-vesicular systems for melanocytes targeting and melasma treatment: In-vitro characterization, ex-vivo skin retention, and preliminary clinical appraisal. Hatem S; Kamel AO; Elkheshen SA; Nasr M; Moftah NH; Ragai MH; El Hoffy NM; Elezaby RS Int J Pharm; 2024 Nov; 665():124731. PubMed ID: 39306205 [TBL] [Abstract][Full Text] [Related]
13. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. Carvalho VFM; Migotto A; Giacone DV; de Lemos DP; Zanoni TB; Maria-Engler SS; Costa-Lotufo LV; Lopes LB Eur J Pharm Sci; 2017 Nov; 109():131-143. PubMed ID: 28735040 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a nanoemulsion containing propranolol for topical delivery. Zanela da Silva Marques T; Santos-Oliveira R; Betzler de Oliveira de Siqueira L; Cardoso VDS; de Freitas ZMF; Barros RCDSA; Villa ALV; Monteiro MSSB; Dos Santos EP; Ricci-Junior E Int J Nanomedicine; 2018; 13():2827-2837. PubMed ID: 29785109 [TBL] [Abstract][Full Text] [Related]
15. Nanocarrier-based topical drug delivery for an antifungal drug. Hussain A; Samad A; Nazish I; Ahmed FJ Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443 [TBL] [Abstract][Full Text] [Related]
16. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches. Gillbro JM; Olsson MJ Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866 [TBL] [Abstract][Full Text] [Related]
17. Combination of elastic liposomes and low frequency ultrasound for skin permeation enhancement of hyaluronic acid. Kasetvatin C; Rujivipat S; Tiyaboonchai W Colloids Surf B Biointerfaces; 2015 Nov; 135():458-464. PubMed ID: 26280820 [TBL] [Abstract][Full Text] [Related]
18. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936 [TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin. Oliveira CA; Gouvêa MM; Antunes GR; Freitas ZMF; Marques FFC; Ricci-Junior E Int J Pharm; 2018 Aug; 547(1-2):1-9. PubMed ID: 29800737 [TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Use of Antioxidants for Melasma. Babbush KM; Babbush RA; Khachemoune A J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]